I

Inovio Pharmaceuticals
D

INO

1.87000
USD
0.10
(5.35%)
مفتوح الان
حجم التداول
15,119
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
67,506,983
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMRN
    0.00350
    (0.78%)
    0.45500 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    A
    ARWR
    -0.770
    (-3.79%)
    19.570 USD
    A
    AXSM
    -2.120
    (-2.34%)
    88.600 USD
    C
    CRSP
    -0.970
    (-2.36%)
    40.140 USD
    E
    EDIT
    -0.02500
    (-1.86%)
    1.32000 USD
    I
    INO
    0.09500
    (5.35%)
    1.87000 USD
    S
    SRPT
    -1.670
    (-1.39%)
    118.530 USD
    V
    VCEL
    -1.870
    (-3.32%)
    54.490 USD
    V
    VKTX
    1.720
    (4.50%)
    39.950 USD
    المزيد
الأخبار

العنوان: Inovio Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.